IQ testing for obese people is challenged

Jan 23, 2007

A U.S. group is challenging an insurance company's requirement that morbidly obese people be given an IQ test before undergoing weight loss surgery.

The Tampa, Fla., Obesity Action Coalition says it believes Blue Cross/Blue Shield of Tennessee is the first insurer to require an IQ test to access any medical treatment.

"Requiring an IQ test to access any medical procedure is wrong and by implementing such a requirement, Blue Cross/Blue Shield of Tennessee is setting a dangerous precedent of denying healthcare based on intelligence testing," said OAC President Joseph Nadglowski Jr. in a statement. "In addition, the testing requirement perpetuates the false notion that those affected by obesity and morbid obesity are of lower intelligence on average then the general public."

Copyright 2007 by United Press International

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Antennae help flies 'cruise' in gusty winds

Apr 10, 2014

Due to its well-studied genome and small size, the humble fruit fly has been used as a model to study hundreds of human health issues ranging from Alzheimer's to obesity. However, Michael Dickinson, Esther ...

Scientist pushes boundaries of food sensory research

Mar 20, 2014

Anyone who has ever been lured by the call of a dozen fat- and sugar-laden donuts in the office break room while a healthy container of yogurt looks on helplessly can relate to Susan Duncan's research regarding ...

Vitamin B12 accelerates worm development

Feb 13, 2014

Everyday our cells take in nutrients from food and convert them into the building blocks that make life possible. However, it has been challenging to pinpoint exactly how a single nutrient or vitamin changes ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

20 hours ago

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Classifying sequence variants in human disease

Sequencing an entire human genome is faster and cheaper than ever before, leading to an explosion of studies comparing the genomes of people with and without a given disease. Often clinicians and researchers studying genetic ...